Alivus Life Sciences Limited
Alivus Life Sciences Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ALIVUS and BSE: 543322 (ISIN INE03Q201024).
It has a market capitalisation of ₹15,570 crore, a last close of ₹1,269 on 2026-10-19, a one-year return of 37.4%.
Valuation: a price-to-earnings ratio of 25.82x, a price-to-book ratio of 4.67x, a dividend yield of 0.4%.
Profitability: return on equity of 18.4%, return on capital employed of 23.6%, an operating margin of 32.3%.
Growth: sales growth of 5.7% a year over three years, net profit growth of 6.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 74.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 15,570 |
| Last close | ₹1,269 |
| P/E (TTM) | 25.82x |
| P/B | 4.67x |
| Dividend yield | 0.4% |
| ROE (FY) | 18.4% |
| ROCE (FY) | 23.6% |
| Operating margin (TTM) | 32.3% |
| Sales growth, 3-year CAGR | 5.7% |
| Profit growth, 3-year CAGR | 6.5% |
| Debt / equity | 0.00x |
| Promoter holding | 74.9% |
| 1-year return | 37.4% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means